NCT00406237
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
- Locations
-
- Pfizer Investigational Site Saint Paul, Minnesota, United States
- Pfizer Investigational Site Durham, North Carolina, United States
- Pfizer Investigational Site Santurce, Puerto Rico